SCHEMBL242958

SCHEMBL242958

O=C(O)c1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.64
ALDH1A1 P00352 5/20 0.64
CYP1A2 P05177 5/20 0.64
KMT2A Q03164 4/20 0.64
HPGD P15428 4/20 0.64
KDM4E B2RXH2 3/20 0.64
GLA P06280 1/20 0.64
POLB P06746 1/20 0.64
CYP2D6 P10635 1/20 0.64
NR4A1 P22736 1/20 0.55
NR4A2 P43354 1/20 0.55
NR4A3 Q92570 1/20 0.55
MEN1 O00255 3/20 0.53
TSHR P16473 3/20 0.53
RXFP1 Q9HBX9 1/20 0.53
WDR5 P61964 1/20 0.52
PTPN1 P18031 1/20 0.52
LDHA P00338 1/20 0.50
MAPT P10636 1/20 0.49
TYMS P04818 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350533 1.00 HSD17B10 (0.64) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
Ammonia Solution, Strong SCHEMBL31590520 0.98 HSD17B10 (0.62) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL28673575 0.98 HSD17B10 (0.62) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
Hydrochloric Acid SCHEMBL8600808 0.98 HSD17B10 (0.62) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
Methyl Alcohol SCHEMBL28488780 0.96 ALDH1A1 (0.60) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
Formaldehyde SCHEMBL28435516 0.96 HSD17B10 (0.60) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL27744196 0.94 ALDH1A1 (0.63) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL4758651 0.91 CYP1A2 (0.55) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL13445966 0.91 CYP1A2 (0.55) HSD17B10ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL19177661 0.89 NR4A1 (0.53) HSD17B10ALDH1A1CYP1A2KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106554-A1 AFTERGLOW MATERIALS AND METHODS OF FABRICATION THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2026-05-21 WO claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
US-12421447-B2 Fluorescent metal organic frameworks (MOFs) for drilling depth correlation and waterfront mapping SAUDI ARABIAN OIL COMPANY (SA) 2025-09-23 US claimed
WO-2025127865-A1 METHOD FOR MANUFACTURING PEROVSKITE NANOCRYSTALS BY USING COLD-INJECTION METHOD, AND PEROVSKITE LIGHT-EMITTING DEVICE COMPRISING PEROVSKITE NANOCRYSTALS MANUFACTURED THEREBY 서울대학교산학협력단 2025-06-19 WO claimed
CN-115343261-B Application of supermolecular gel in selective identification of sialic acid and sialic acid sugar chains 中国科学院大连化学物理研究所 2025-05-06 CN claimed
CN-119859260-A High-conductivity polymer transmission layer material and preparation method thereof 太原理工大学 2025-04-22 CN claimed
CN-119841727-A Method for directly preparing carboxylic ester compound from aromatic aldehyde, ketone and carboxylic acid 湖南第一师范学院 2025-04-18 CN claimed
US-20250127028-A1 PEROVSKITE LIGHT-EMITTING LAYER AND DEVICE USING THE SAME SN DISPLAY CO LTD (KR) 2025-04-17 US claimed
CN-116178160-B Chiral compound based on cycloparaffin derivative and synthetic method and application thereof 安徽大学 2025-03-28 CN claimed
CN-119504343-A Meta-methyl chlorobenzyl production process and production system thereof 安徽苏乐医药材料有限公司 2025-02-25 CN claimed
WO-2007061574-A2 ROOM TEMPERATURE PHOSPHORESCENCE APPARATUS AND METHODS SCA RESEARCH, LLC (US) 2007-05-31 WO claimed
US-20070117215-A1 Room temperature phosphorescence apparatus and methods POLYMER CONCEPTS TECHNOLOGIES PBY, INC. 2007-05-24 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP claimed
US-4353912-A NEUROLEPTIC AGENTS NORTHEASTERN UNIVERSITY (US) 1982-10-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250127028-A1 PEROVSKITE LIGHT-EMITTING LAYER AND DEVICE USING THE SAME TYR, BMI1, MITF HSD17B10 2876/4885ALDH1A1 1053/4885CYP1A2 2435/4885
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 HSD17B10 2219/4885ALDH1A1 1569/4885CYP1A2 1066/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 HSD17B10 2365/4885ALDH1A1 1723/4885CYP1A2 968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.